India Glycols Limited reported a strong FY26 performance, with gross revenues reaching INR 9,827 crores, up 8.7%, and a significant rise in net revenue to INR 4,211 crores. The company achieved an EBITDA of INR 654 crores, reflecting a 24.5% year-over-year increase. The growth was driven by consistent demand in Potable Spirits, Bio-Fuels, and Chemicals, alongside a successful strategic shift toward high-margin premium products and enhanced operational efficiencies.
Financial Performance Highlights
India Glycols demonstrated robust financial growth for the full year FY26. The company achieved a PAT of INR 293 crores, marking a 26.8% increase, while the EBITDA margin expanded to 15.5%. For the final quarter of the fiscal year, net revenue stood at INR 976 crores, an increase of 13.1% compared to the same period in the previous year, bolstered by strong performance across all business segments.
Segment-Wise Performance
The Bio-Fuels business led the momentum with a remarkable 40.9% growth, delivering a top-line of INR 1,470 crores. This success is tied to India achieving 20% ethanol blending ahead of schedule. The Potable Spirits segment also saw significant growth, with a 14.4% increase in top-line to INR 1,331 crores, driven by a strategic focus on premiumization and successful new product launches like Amrut’s Prestige Whisky and various Amazing Vodka flavors.
Strategic Initiatives and Debt Management
The company has prioritized debt reduction, successfully prepaying approximately INR 804 crores during the quarter, funded by an equity issue and internal cash flows. Management remains focused on improving the quality of the Chemicals business, shifting toward higher value-added products and utilizing in-house ethanol as an intermediate. Furthermore, the company is actively working toward becoming debt-free in the chemical segment by FY28-29 through the phased monetization of its joint venture.
Future Outlook
Looking ahead, the management team is optimistic about maintaining this growth trajectory. With a strong pipeline of performance chemicals, continued expansion of the premium liquor portfolio, and strategic investments in Ennature Biopharma, India Glycols is well-positioned to drive profitability. The company expects that its ongoing focus on high-margin products and cost optimization will continue to enhance shareholder value in the upcoming fiscal years.
Source: BSE
